Literature DB >> 27069421

Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.

Lise J Estcourt1, Patricia M Fortin2, Sally Hopewell3, Marialena Trivella4.   

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To summarize the evidence in Cochrane reviews of the effectiveness and safety of red cell transfusions versus no transfusion, or restrictive (to increase the total haemoglobin) versus liberal (to decrease the haemoglobin S level below a specified percentage) transfusion, for treatment or prevention of complications experienced by people with SCD.

Entities:  

Year:  2016        PMID： 27069421      PMCID： PMC4826604          DOI： 10.1002/14651858.CD012082

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN： 1361-6137


  31 in total

Review 1.  Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease.

Authors:  Gavin Cho; Ian R Hambleton
Journal:  Cochrane Database Syst Rev       Date:  2014-01-08

2.  Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.

Authors:  Gregory J Kato; Vicki McGowan; Roberto F Machado; Jane A Little; James Taylor; Claudia R Morris; James S Nichols; Xunde Wang; Mirjana Poljakovic; Sidney M Morris; Mark T Gladwin
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

3.  Epidemiology: a moving target.

Authors:  Simon Pleasants
Journal:  Nature       Date:  2014-11-13       Impact factor: 49.962

4.  Sickle-cell disease.

Authors:  Lauren Gravitz; Stephen Pincock
Journal:  Nature       Date:  2014-11-13       Impact factor: 49.962

Review 5.  Sickle-cell disease.

Authors:  David C Rees; Thomas N Williams; Mark T Gladwin
Journal:  Lancet       Date:  2010-12-03       Impact factor: 79.321

Review 6.  Preoperative blood transfusions for sickle cell disease.

Authors:  Ceri Hirst; Lorna Williamson
Journal:  Cochrane Database Syst Rev       Date:  2012-01-18

Review 7.  Interplay between coagulation and vascular inflammation in sickle cell disease.

Authors:  Erica Sparkenbaugh; Rafal Pawlinski
Journal:  Br J Haematol       Date:  2013-04-18       Impact factor: 6.998

8.  High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.

Authors:  Stella T Chou; Tannoa Jackson; Sunitha Vege; Kim Smith-Whitley; David F Friedman; Connie M Westhoff
Journal:  Blood       Date:  2013-05-30       Impact factor: 22.113

9.  Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates.

Authors:  Frédéric B Piel; Anand P Patil; Rosalind E Howes; Oscar A Nyangiri; Peter W Gething; Mewahyu Dewi; William H Temperley; Thomas N Williams; David J Weatherall; Simon I Hay
Journal:  Lancet       Date:  2012-10-25       Impact factor: 79.321

10.  The co-inheritance of alpha-thalassemia and sickle cell anemia is associated with better hematological indices and lower consultations rate in Cameroonian patients and could improve their survival.

Authors:  Maryam Bibi Rumaney; Valentina Josiane Ngo Bitoungui; Anna Alvera Vorster; Raj Ramesar; Andre Pascal Kengne; Jeanne Ngogang; Ambroise Wonkam
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240
View more
  7 in total

Review 1.  Knowledge insufficient: the management of haemoglobin SC disease.

Authors:  Lydia H Pecker; Beverly A Schaefer; Lori Luchtman-Jones
Journal:  Br J Haematol       Date:  2016-12-16       Impact factor: 6.998

2.  Hemoglobin S monitoring on TOSOH G8 in hemoglobin A1c mode in case of urgent red blood cell exchange.

Authors:  Sophie Van Aelst; Helena Claerhout; Elke Nackers; Koen Desmet; Davy Kieffer
Journal:  J Clin Lab Anal       Date:  2018-04-18       Impact factor: 2.352

Review 3.  Engineering the Surface of Therapeutic "Living" Cells.

Authors:  Jooyeon Park; Brenda Andrade; Yongbeom Seo; Myung-Joo Kim; Steven C Zimmerman; Hyunjoon Kong
Journal:  Chem Rev       Date:  2018-01-16       Impact factor: 60.622

4.  Simple chronic transfusion therapy, a crucial therapeutic option for sickle cell disease, improves but does not normalize blood rheology: What should be our goals for transfusion therapy?

Authors:  Jon A Detterich
Journal:  Clin Hemorheol Microcirc       Date:  2018       Impact factor: 2.375

5.  An introduction to overviews of reviews: planning a relevant research question and objective for an overview.

Authors:  Harriet Hunt; Alex Pollock; Pauline Campbell; Lise Estcourt; Ginny Brunton
Journal:  Syst Rev       Date:  2018-03-01

Review 6.  Commonly used agent for acute pain management of sickle cell anemia in Saudi Emergency Department: A narrative review.

Authors:  Reem A Hejazi; Nameer A Mandourah; Aryaf S Alsulami; Hussain T Bakhsh; Reem M Diri; Ahmad O Noor
Journal:  Saudi Pharm J       Date:  2021-02-16       Impact factor: 4.330

Review 7.  Selecting and implementing overview methods: implications from five exemplar overviews.

Authors:  Alex Pollock; Pauline Campbell; Ginny Brunton; Harriet Hunt; Lise Estcourt
Journal:  Syst Rev       Date:  2017-07-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.